Abstract
A new method using surface plasmon resonance (SPR) through the BIAcore was used to demonstrate the specific interaction between an anti-CD4 monoclonal antibody (IOT4a), adsorbed on poly(methylidene malonate 2.1.2) (PMM 2.1.2) nanoparticles, and the CD4 molecule. The results obtained were compared with the interaction of the same immunonanoparticles with rabbit anti-mouse Fc antibodies. The molar ratio (Fc)/(Fab) was 1, suggesting that the same number of epitopes on the Fc and the Fab fragments were accessible after IOT4a adsorption onto nanoparticles. Comparing the observed association rates of free antibody and antibody adsorbed on nanoparticles, the number of molecules of IOT4a antibody on PMM 2.1.2 nanoparticles was estimated as between 2.6 and 3 per nanoparticle. The properties of the antibody-coated nanoparticles are compatible with their use as antibody-targeted pharmacophores.
Similar content being viewed by others
Abbreviations
- rsCD4:
-
recombinant soluble cluster differentiation 4
- HIV-1:
-
human immunodeficiency virus type 1
- RU:
-
resonance unit
- Np:
-
nanoparticles
- Np-Ab:
-
anti-CD4 immunonanoparticles
References
Krowka, J., Stites, D., Debs, R., Larsen, C., Fedor, J., Brunette, E., and Düzgünes, N., J. Immun.144 (1990) 2535.
Roche, A. C., Bailly, P., and Monsigny, M., Invas. Metastasis5 (1985) 218.
Peeters, P. A. M., Storm, G., and Crommelin, D. J. A., Adv. Drugs Rev.1 (1987) 249.
Allémann, E., Gurny, R., and Doelker, E., Eur. J. Pharmac. Biopharmac.39 (1993) 173.
Couvreur, P., and Vauthier, C., J. Controlled Rel.17 (1991) 187.
Lescure, F., Seguin, C., Breton, P., Bourrinet, P., Roy, D., and Couvreur, P., Pharmac. Res.11 (1994) 1270.
Breton, P., Roy, D., Marchal-Heussler, L., Seguin, C., Couvreur, P., and Lescure, F., in: Targeting of Drugs, p. 161. Eds G. Gregoriadis, B. McCormack and J. Poste, Plenum Press, New York 1994.
Kubiak, C., Manil, L., and Couvreur, P., Int. J. Pharmac.41 (1988) 181.
Breton, P., Guillon, X., Roy, D., Tamas, S., Marchal-Heussler, L., Bru, N., and Lescure, F., Eur. J. Pharmac. Biopharmac.43 (1996) 95.
Bru-Magniez, N., Chermann, J. C. Lescure, F., Teulon, J. M., and Breton, P., (1994) World Patent PCT WO 94/24168.
Velge-Roussel, F., Breton, P., Lescure, F., Guillon, X., Bout, D., and Hoebeke, J., J. Immun. Meth.183 (1995) 141.
Löfas, S., and Johnson, B., J. Chem. Soc. Chem. Commun.21 (1990) 1526.
Johnsson, B., Löfas, S., and Linquist, G., Analyt. Biochem.198 (1991) 268.
Illum, L., Jones, P. D. E., Kreuter, J., Baldwin, R. W., and Davis, S. S., Int. J. Pharmac.17 (1983) 65.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Velge-Roussel, F., Breton, P., Guillon, X. et al. Immunochemical characterization of antibody-coated nanoparticles. Experientia 52, 803–806 (1996). https://doi.org/10.1007/BF01923993
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01923993